Yamaguchi, Japan

Masaaki Matoyama

This inventor holds 1 USPTO granted patent. Top assignees: Shionogi & Co., Ltd., Ube Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Matoyama. Retrieved from https://idiyas.com/inventor/masaaki-matoyama-uqso6c9z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaaki Matoyama: Innovator in Antiviral Compounds

Introduction

Masaaki Matoyama is a notable inventor based in Yamaguchi, Japan. He has made significant contributions to the field of antiviral compounds, showcasing his expertise through his innovative work.

Latest Patents

Masaaki Matoyama holds a patent for an amide derivative having antiviral activity. The invention provides a compound represented by a specific formula, which includes various chemical components designed to exhibit antiviral properties. This compound is not only a breakthrough in antiviral research but also includes a pharmaceutical composition that utilizes the compound effectively.

Career Highlights

Throughout his career, Masaaki Matoyama has worked with prominent companies such as Shionogi & Co., Ltd. and Ube Corporation. His experience in these organizations has allowed him to develop and refine his skills in pharmaceutical innovation.

Collaborations

Masaaki Matoyama has collaborated with notable colleagues, including Azusa Okano and Kouhei Nodu. These partnerships have contributed to his success and the advancement of his research in antiviral compounds.

Conclusion

Masaaki Matoyama's work in developing antiviral compounds highlights his innovative spirit and dedication to improving healthcare. His contributions continue to influence the field of pharmaceuticals and inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…